Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Licheng Pharmaceutical Technology Co., Ltd. is a high-tech pharmaceutical enterprise based in Nanjing, China, that specializes in the research, development, and production of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. The company focuses on a dual strategy of developing high-end generic drugs and innovative small molecule therapeutics, particularly in the fields of cardiovascular health, oncology, and anti-infectives. Licheng Pharmaceutical operates integrated R&D centers and GMP-compliant manufacturing facilities to serve both domestic and international markets. By leveraging its expertise in chemical synthesis and formulation, the company aims to provide affordable and effective medical solutions while advancing its own pipeline of proprietary drug candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Licheng Pharmaceutical.